$1.02
2.00% yesterday
Nasdaq, Jul 18, 10:17 pm CET
ISIN
US67577C1053
Symbol
OCGN
Sector
Industry

Ocugen Inc Stock price

$1.02
-0.07 6.42% 1M
+0.31 43.66% 6M
+0.22 26.71% YTD
-0.62 37.61% 1Y
-1.46 58.87% 3Y
+0.77 311.29% 5Y
-395.58 99.74% 10Y
-703.98 99.86% 20Y
Nasdaq, Closing price Fri, Jul 18 2025
+0.02 2.00%
ISIN
US67577C1053
Symbol
OCGN
Sector
Industry

Key metrics

Basic
Market capitalization
$292.0m
Enterprise Value
$281.9m
Net debt
positive
Cash
$37.8m
Shares outstanding
292.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
52.7 | 113.8
EV/Sales
50.9 | 109.9
EV/FCF
negative
P/B
18.4
Financial Health
Equity Ratio
35.9%
Return on Equity
-182.4%
ROCE
-145.6%
ROIC
-
Debt/Equity
1.7
Financials (TTM | estimate)
Revenue
$5.5m | $2.6m
EBITDA
$-66.6m | -
EBIT
$-69.3m | $-63.0m
Net Income
$-69.4m | $-68.5m
Free Cash Flow
$-52.0m
Growth (TTM | estimate)
Revenue
-21.4% | -36.8%
EBITDA
-12.3% | -
EBIT
-15.5% | -15.0%
Net Income
-18.6% | -26.8%
Free Cash Flow
20.8%
Margin (TTM | estimate)
Gross
-
EBITDA
-1,202.3% | -
EBIT
-1,251.1%
Net
-1,253.7% | -2,669.9%
Free Cash Flow
-938.5%
More
EPS
$-0.3
FCF per Share
$-0.2
Short interest
22.7%
Employees
95
Rev per Employee
$40.0k
Show more

Is Ocugen Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,009 stocks worldwide.

Ocugen Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Ocugen Inc forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a Ocugen Inc forecast:

Buy
90%
Hold
10%

Financial data from Ocugen Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
5.54 5.54
21% 21%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 33 33
10% 10%
598%
- Research and Development Expense 42 42
13% 13%
752%
-67 -67
12% 12%
-1,201%
- Depreciation and Amortization 2.70 2.70
280% 280%
49%
EBIT (Operating Income) EBIT -69 -69
15% 15%
-1,250%
Net Profit -69 -69
19% 19%
-1,253%

In millions USD.

Don't miss a Thing! We will send you all news about Ocugen Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Ocugen Inc Stock News

Neutral
GlobeNewsWire
about 14 hours ago
MALVERN, Pa., July 18, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the first patient has been dosed in its Phase 2/3 GARDian3 clinical trial for OCU410ST (AAV5-hRORA)—a modifier gene therapy candidate being developed for all Stargardt disease (ABCA4-associated retin...
Neutral
GlobeNewsWire
one day ago
MALVERN, Pa., July 17, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast to discuss the Company's second quarter 2025 financial results and provide a business update at 8:30 a.m. ET on Friday, August 1, 2025.
Neutral
GlobeNewsWire
26 days ago
PHILADELPHIA and MALVERN, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Carisma Therapeutics Inc. (Nasdaq: CARM) (Carisma) and OrthoCellix, Inc. (OrthoCellix), a wholly-owned subsidiary of Ocugen, Inc. (Nasdaq: OCGN) (Ocugen), a clinical-stage company developing regenerative cell therapies for orthopedic diseases, today jointly announced that they have entered into a definitive merger agreement to com...
More Ocugen Inc News

Company Profile

Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. Its pipeline includes OCU400, OCU410, OCU200, OCU200, and OCU300. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA.

Head office United States
CEO Shankar Musunuri
Employees 95
Founded 2013
Website ocugen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today